← Leaderboards
Dario Marchetti
University Of New Mexico Health Scis Ctr
$7,515,916
Attributed
$7,515,916
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $767.7K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,515,916 · 5
By mechanism
R01$7,251,944 · 4
R21$263,972 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico Health Scis Ctr
Same institution · by research overlap
- Nancy L Kanagy$5,652,136
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPhenotypeNeoplasm MetastasisAffectSignal TransductionMetastatic Malignant Neoplasm To BrainHeparanaseBrainGrowthBaseHomingEffective TherapyPathway InteractionsPhosphorylationMediatingSmall MoleculeCell ProliferationAutomobile DrivingIn VitroMelanomaTechnologyMorbidity - Disease RatePreventMalignant Neoplasms
Grant awards (33)
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$161,500
R01 · FY2024 · CA · contact PI
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$359,008
R01 · FY2023 · CA · contact PI
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$359,035
R01 · FY2022 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$326,787
R01 · FY2021 · CA · contact PI
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$174,462
R01 · FY2021 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$30,114
R01 · FY2020 · CA · contact PI
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$324,705
R01 · FY2019 · CA · contact PI
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$53,548
R01 · FY2019 · CA · contact PI
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF$404,950
R01 · FY2018 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$306,904
R01 · FY2018 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$55,884
R01 · FY2018 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$290,229
R01 · FY2017 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$363,699
R01 · FY2016 · CA · contact PI
Functional characterization of brain-colonizing breast cancer CTC subsets$376,502
R01 · FY2015 · CA · contact PI
Heparanase Mechanisms in Brain-metastatic Breast Cancer$303,050
R01 · FY2015 · CA · contact PI
Heparanase Mechanisms in Brain-metastatic Breast Cancer$288,430
R01 · FY2014 · CA · contact PI
Heparanase Mechanisms in Brain-metastatic Breast Cancer$279,509
R01 · FY2013 · CA · contact PI
Heparanase Mechanisms in Brain-metastatic Breast Cancer$297,350
R01 · FY2012 · CA · contact PI
Heparanase Mechanisms in Brain-metastatic Breast Cancer$297,350
R01 · FY2011 · CA · contact PI
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA$279,192
R01 · FY2010 · CA · contact PI
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA$279,192
R01 · FY2009 · CA · contact PI
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA$279,192
R01 · FY2008 · CA · contact PI
Molecular Determinants of Brain metastatic Melanoma$49,980
R01 · FY2006 · CA · contact PI
Molecular Determinants of Brain metastatic Melanoma$244,020
R01 · FY2005 · CA
INVERSE METASTATIC MODALITIES BY HEPARANASES$132,300
R21 · FY2005 · CA
Molecular Determinants of Brain metastatic Melanoma$115,952
R01 · FY2005 · CA
Molecular Determinants of Brain metastatic Melanoma$244,020
R01 · FY2004 · CA
INVERSE METASTATIC MODALITIES BY HEPARANASES$131,672
R21 · FY2004 · CA
Molecular Determinants of Brain metastatic Melanoma$113,003
R01 · FY2004 · CA
Molecular Determinants of Brain metastatic Melanoma$244,020
R01 · FY2003 · CA
Molecular Determinants of Brain metastatic Melanoma$102,187
R01 · FY2003 · CA
Molecular Determinants of Brain metastatic Melanoma$244,020
R01 · FY2001 · CA
Molecular Determinants of Brain metastatic Melanoma$4,150
R01 · FY2001 · CA